Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.88 USD | +1.04% | -2.20% | +12.70% |
Financials (USD)
Sales 2024 * | 231M | Sales 2025 * | 233M | Capitalization | 235M |
---|---|---|---|---|---|
Net income 2024 * | 13M | Net income 2025 * | 14M | EV / Sales 2024 * | 1.02 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.01 x |
P/E ratio 2024 * |
18.9
x | P/E ratio 2025 * |
28.9
x | Employees | 185 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.88% |
Latest transcript on Puma Biotechnology, Inc.
1 day | +1.04% | ||
1 week | -2.20% | ||
Current month | -7.92% | ||
1 month | -12.70% | ||
3 months | -1.41% | ||
6 months | +118.83% | ||
Current year | +12.70% |
Managers | Title | Age | Since |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 18-11-04 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 18-02-22 |
Jay Moyes
BRD | Director/Board Member | 70 | 12-04-26 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 4.88 | +1.04% | 231,234 |
24-04-24 | 4.83 | -5.85% | 365,894 |
24-04-23 | 5.13 | -0.77% | 293,869 |
24-04-22 | 5.17 | +3.19% | 265,410 |
24-04-19 | 5.01 | +0.40% | 290,457 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.70% | 233M | |
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |
- Stock Market
- Equities
- PBYI Stock